This site is intended for health professionals only
Tuesday 23 October 2018
Share |

CE Mark for JuniorSTAR®

Sanofi (EURONEXT: SAN and NYSE: SNY) has announced at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD), Barcelona, the CE Mark of JuniorSTAR®, a new half unit insulin reusable pen that can be used with Lantus® (insulin glargine), Apidra® (insulin glulisine) or Insuman® (recombinant human insulin).

Ads by Google